Post-IPO Equity Health Diagnostics Companies

Quantum SI offers Next Generation Protein Sequencing that makes diagnostics digital.

FOXO Technologies transforms the global longevity insurance industry with a next-generation underwriting protocol.

ZyVersa is committed to improving health outcomes and quality of life for patients with inflammatory and renal diseases.

Alzamend Neuro is an innovative biotechnology company that develops and commercializes drugs, treatments, and cures for Alzheimer's disease.

Personalis is a contract research organization and genome-scale diagnostics services company specializing in genome guided medicine.

CG Oncology is a clinical-stage biopharmaceutical company focused on the development of oncolytic immunotherapies to combat cancer.

CMT focuses on the development and commercialization of regenerative therapies derived from novel processed human platelets.

Janux Therapeutics develops immunotherapies that generates immune responses to prevent tumors and not affecting a patient’s healthy tissue.

Atlantic Coastal Acquisition Corp. II is a blank check company.

BCAL Diagnostics is a biotechnology company that focuses on the detection of women’s health issues.

Cloud DX's Connected Health remote patient monitoring platform is used by healthcare enterprises and care teams.

Unicycive Therapeutics provides development programs that focus on treating kidney diseases with unmet medical needs.

Arcutis Biotherapeutics is a clinical-stage biopharmaceutical company focused on developing medical dermatology for unmet needs.

BioSenic is a forward-thinking firm that aims to address critical unmet medical needs.

Comera Life Sciences Holdings is an engineering superior biotherapeutic formulations for fragile patients.

Pioneering advanced cancer diagnostics and regenerative medicine treatments.

Ikena Oncology develops differentiated therapies to target cancer growth and resistance, focusing on Hippo and RAS signaling pathways.

Orchard Therapeutics is a biotechnology company dedicated to assisting patients through innovative gene therapies.

LumiraDx is a healthcare company that manufactures a diagnostic platform to support a menu of tests with lab comparable performance.

GeneDx uses artificial intelligence and machine learning to analyze patient data to provide insights to transform the practice of medicine.

Pliant Therapeutics focuses on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.

Prothena is a clinical-stage neuroscience company focused on the discovery and development of novel therapies.

Cognetivity Neurosciences is a Platform technology for early, rapid and easy detection of dementia.

Kezar Life Sciences company focused on the discovery and development of drugs targeting protein homeostasis for autoimmune disorders

Axonics Modulation Technologies is a pre-revenue company developing novel implantable neuromodulation.